Biotech startups in Sweden
Updated 16 Nov 2026
Not sure about the data?
Download a free 10-row sample first. No account, no payment.
| Company | City | Last round | Amount | Date |
|---|---|---|---|---|
| Mavatar | Stockholm | Seed | $3.9M | 2024-09-01 |
| Moleculent | Solna | Series A | $20.0M | 2026-04-30 |
| Asgard Therapeutics | Lund | Series A | $32.6M | 2024-03-14 |
| Cellevate | Lund | Seed | $2.2M | 2026-03-30 |
| Pixelgen Technologies | Stockholm | Series B | $15.5M | 2026-08-20 |
| Single Technologies | Stockholm | Seed | $11.6M | 2025-06-24 |
| Seaqure Labs AB | Gothenburg | Pre-seed | $546K | 2025-08-21 |
| Trackpaw Scientific | Lund | Seed | $2.7M | 2025-08-18 |
8 rows of the CSV in 5 of its 18 columns.
- The 66 biotech startups in Sweden have raised $585.1M in total.
- 9 of them closed their most recent round in the last 12 months, $112.0M combined.
- The largest of those rounds is AnaCardio's $70.8M Series B, dated September 2026.
- The most recent is Hydro Diagnostics' $339K seed round on 1 October 2026.
- Industrifonden is an investor in 3 of them, more than any other fund.
- Health care is the most common other sector, with 49 companies (74%).
- 44% were founded in 2020 or later; the median founding year is 2018.
- The most common team size is 1 to 10 employees (68% of companies with a recorded size).
Source: FundingWatcher. Data as of 16 November 2026. "Last 12 months" is the 365 days to that date.
Newest rounds
12 of 66| Company | What they do | Sector | City | Last round | Amount | Date | Total raised | Investors | Employees | Founded |
|---|---|---|---|---|---|---|---|---|---|---|
| Pixelgen Technologies | Pixelgen Technologies develops technologies for biomedical research and diagnostics. | Biotech | Stockholm | Series B | $15.5M | 2026-08-20 | $43.5M | Industrifonden, Navigare Ventures, Colibri Ventures +1 | 11 to 50 | 2020 |
| Moleculent | Moleculent is a biotechnology research company. | Biotech | Solna | Series A | $20.0M | 2026-04-30 | $46.0M | ARCH Venture Partners, EIR Ventures | 11 to 50 | 2021 |
| Cellevate | Cellevate develops cell culture systems for biotech research and production. | Biotech | Lund | Seed | $2.2M | 2026-03-30 | $12.1M | European Innovation Council, Industrifonden, Onsight Ventures +1 | 11 to 50 | 2014 |
| Seaqure Labs AB | Seaqure Labs develops mycoprotein-based alternatives to current unsustainable methods used in aquaculture. | Biotech | Gothenburg | Pre-seed | $546K | 2025-08-21 | $1.1M | Chalmers Ventures AB | 1 to 10 | 2024 |
| Trackpaw Scientific | TrackPaw Scientific develops and commercializes a technology platform for accelerating medication development. | Biotech | Lund | Seed | $2.7M | 2025-08-18 | $3.1M | Almi Invest, I Love Lund, LU Holding | 1 to 10 | 2022 |
| Single Technologies | Single Technologies develops a 3-D DNA sequencing system. | Artificial intelligence | Stockholm | Seed | $11.6M | 2025-06-24 | $28.6M | Almi Invest, Sting, KTH Holding +1 | 11 to 50 | 2014 |
| Mavatar | Mavatar develops AI and digital twin technology to reduce medication errors. | Artificial intelligence | Stockholm | Seed | $3.9M | 2024-09-01 | Collinstar Capital | 11 to 50 | 2021 | |
| Nygen Analytics | Nygen Analytics provides cloud-based tools for cost-effective analysis of single-cell genomic data. | Biotech | Lund | Seed | $734K | 2024-08-29 | $734K | Fåhraeus Startup and Growth, SmiLe Inject Capital | 1 to 10 | 2021 |
| BrainZell | BrainZell uses stem cell-based models that more closely match the human brain than animal models. | Biotech | Stockholm | Seed | $1.5M | 2024-06-03 | Sting, Norrsken Evolve | 1 to 10 | 2020 | |
| Asgard Therapeutics | Asgard Therapeutics is a biotechnology company developing new therapies. | Biotech | Lund | Series A | $32.6M | 2024-03-14 | $39.6M | Novo Holdings, Industrifonden, Boehringer Ingelheim Venture Fund +2 | 11 to 50 | 2018 |
| TIGERQ | TIGERQ offers a sample-to-analysis gene editing solution built on proprietary sequencing algorithms. | Biotech | Lund | Seed | $1.2M | 2021-03-17 | SmiLe Incubator | 1 to 10 | 2018 | |
| Envue Technologies | Envue Technologies provides a technique for studying extremely small particles in a new way. | Biotech | Gothenburg | Pre-seed | $5K | 2020-01-30 | $5K | Chalmers Ventures AB | 1 to 10 | 2020 |
Table 1. Biotech startups in Sweden: the 12 newest rounds whose row carries a description, a city, a named fund and an amount. Source: FundingWatcher. Data as of 16 November 2026. Base: 66.
Largest rounds
Last 12 months| # | Company | What they do | Sector | City | Last round | Amount | Date | Total raised | Investors | Employees | Founded |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Moleculent | Moleculent is a biotechnology research company. | Biotech | Solna | Series A | $20.0M | 2026-04-30 | $46.0M | ARCH Venture Partners, EIR Ventures | 11 to 50 | 2021 |
| 2 | Pixelgen Technologies | Pixelgen Technologies develops technologies for biomedical research and diagnostics. | Biotech | Stockholm | Series B | $15.5M | 2026-08-20 | $43.5M | Industrifonden, Navigare Ventures, Colibri Ventures +1 | 11 to 50 | 2020 |
| 3 | Cellevate | Cellevate develops cell culture systems for biotech research and production. | Biotech | Lund | Seed | $2.2M | 2026-03-30 | $12.1M | European Innovation Council, Industrifonden, Onsight Ventures +1 | 11 to 50 | 2014 |
Table 2. Biotech startups in Sweden: the 3 largest rounds of the last 12 months. Source: FundingWatcher. Data as of 16 November 2026.
Most active investors
By companies backed| # | Investor | Type | Location | Companies | Share | Funded, 12 months | Latest |
|---|---|---|---|---|---|---|---|
| 1 | Industrifonden | Venture capital firm | Stockholm, Sweden | 3 | 5% | 2 | Pixelgen Technologies, Cellevate |
| 2 | Chalmers Ventures AB | Venture capital firm | Gothenburg, Sweden | 3 | 5% | ||
| 3 | SmiLe Incubator | Startup accelerator | Lund, Sweden | 2 | 3% | 1 | Cellevate |
| 4 | Almi Invest | Venture capital firm | Stockholm, Sweden | 2 | 3% | ||
| 5 | Sting | Startup accelerator | Stockholm, Sweden | 2 | 3% | ||
| 6 | Collinstar Capital | Venture capital firm | Melbourne, Australia | 1 | 2% | ||
| 7 | EIR Ventures | Venture capital firm | Stockholm, Sweden | 1 | 2% | 1 | Moleculent |
| 8 | ARCH Venture Partners | Venture capital firm | Chicago, United States | 1 | 2% | 1 | Moleculent |
| 9 | Johnson & Johnson Innovation | Corporate venture arm | Cambridge, United States | 1 | 2% | ||
| 10 | LU Innovation | Venture capital firm | Lund, Sweden | 1 | 2% | ||
| 11 | Boehringer Ingelheim Venture Fund | Corporate venture arm | Ingelheim Am Rhein, Germany | 1 | 2% | ||
| 12 | Novo Holdings | Corporate venture arm | Hellerup, Denmark | 1 | 2% | ||
| 13 | Onsight Ventures | Venture capital firm | Innsbruck, Austria | 1 | 2% | 1 | Cellevate |
| 14 | European Innovation Council | Startup accelerator | Brussels, Belgium | 1 | 2% | 1 | Cellevate |
| 15 | Colibri Ventures | Venture capital firm | Solna, Sweden | 1 | 2% | 1 | Pixelgen Technologies |
Table 3. Biotech startups in Sweden: the funds recorded as investors in the most companies. Latest: companies they back that raised in the last 12 months. Source: FundingWatcher. Data as of 16 November 2026.
Sectors
| Sectors | Companies | Share | Total raised |
|---|---|---|---|
| Health care | 49 | 74% | $477.7M |
| Software | 8 | 12% | $30.8M |
| Artificial intelligence | 5 | 8% | $30.8M |
| Hardware | 3 | 5% | $2.2M |
| Fintech | 1 | 2% | $1.2M |
Table 4. Biotech startups in Sweden by sector. Source: FundingWatcher. Data as of 16 November 2026.
Funding stage
| Funding stage | Companies | Share | Median last round |
|---|---|---|---|
| Pre-seed | 15 | 23% | $474K |
| Seed | 33 | 50% | $734K |
| Series A | 12 | 18% | $5.0M |
| Series B | 4 | 6% | $15.5M |
| Series C | 1 | 2% | $41.0M |
| Series D+ | 1 | 2% | $34.1M |
Table 5. Biotech startups in Sweden by stage of the most recent round. Source: FundingWatcher. Data as of 16 November 2026.
Cities
| Cities | Companies | Share |
|---|---|---|
| Stockholm | 18 | 27% |
| Gothenburg | 11 | 17% |
| Solna | 8 | 12% |
| Lund | 8 | 12% |
| Uppsala | 5 | 8% |
| Mölndal | 4 | 6% |
| Malmö | 3 | 5% |
| Linköping | 2 | 3% |
| Limhamn | 1 | 2% |
| Västerås | 1 | 2% |
| Bromma | 1 | 2% |
| Umeå | 1 | 2% |
Table 6. Biotech startups in Sweden by headquarters city. Source: FundingWatcher. Data as of 16 November 2026.
Rounds by month
| Rounds by month | Companies | Share | Raised |
|---|---|---|---|
| October 2026 | 1 | 11% | $339K |
| September 2026 | 2 | 22% | $72.2M |
| August 2026 | 1 | 11% | $15.5M |
| July 2026 | 1 | 11% | $515K |
| June 2026 | 2 | 22% | $1.2M |
| April 2026 | 1 | 11% | $20.0M |
| March 2026 | 1 | 11% | $2.2M |
Table 7. Biotech startups in Sweden: most recent round by month, last 12 months. Source: FundingWatcher. Data as of 16 November 2026.
Most recent round by year
| Most recent round by year | Companies | Share | Raised |
|---|---|---|---|
| 2026 | 9 | 14% | $112.0M |
| 2025 | 9 | 14% | $53.8M |
| 2024 | 10 | 15% | $43.9M |
| 2023 | 5 | 8% | $1.4M |
| 2022 | 4 | 6% | $9.9M |
| 2021 | 6 | 9% | $12.4M |
Table 8. Biotech startups in Sweden by year of the most recent round. Source: FundingWatcher. Data as of 16 November 2026.
Founding year
| Founding year | Companies | Share |
|---|---|---|
| 2023 or later | 7 | 11% |
| 2020 to 2022 | 22 | 33% |
| 2015 to 2019 | 15 | 23% |
| 2010 to 2014 | 14 | 21% |
| Before 2010 | 8 | 12% |
Table 9. Biotech startups in Sweden by founding year. Source: FundingWatcher. Data as of 16 November 2026.
Team size
| Team size | Companies | Share |
|---|---|---|
| 1 to 10 | 44 | 68% |
| 11 to 50 | 20 | 31% |
| 51 to 100 | 1 | 2% |
Table 10. Biotech startups in Sweden by headcount. Source: FundingWatcher. Data as of 16 November 2026.
Method
- A company is on this list when Biotech is one of its sectors and its headquarters is in Sweden. On 16 November 2026 that is 66 companies.
- Stage, round, amount and date are those of the company's most recent funding round. Amounts are in US dollars as the source records them.
- The table prints the 12 newest rounds whose row is complete: a one-sentence description, a city, a named fund and an amount. The CSV carries all 66 rows: 10 have no round amount, 0 no city and 24 no website. The CSV carries domain, website, LinkedIn and the cached description sentence where present.
Sources, fields and exclusions of both files: Method.
Questions
- How many biotech startups in Sweden are on the list?
- 66, in the file dated 16 November 2026. 9 of them closed their most recent round in the last 12 months.
- What does the CSV contain?
- One row per company, 18 columns: name, domain, website, linkedin, description, founded, employees, city, region, country, sectors, funding_stage, last_round, last_round_date, last_round_usd, total_raised_usd, rounds, investors.
- How much does the list cost?
- $29 one-time for all 66 rows, no account. Every investor and every startup, two files, cost $99. With founder contacts, up to 2 founders or CEOs per company compiled to order and mailed within 24 hours, $199.
- What arrives after payment?
- At once: the CSV download link, on the page after payment and by mail.
- Can I see rows before buying?
- The 3 rows under the buy button are rows of the CSV with every column. The form below it mails 10 rows.
- How current is the data?
- The file is dated 16 November 2026. The download link serves the current file each time it is opened.
Not sure about the data?
Download a free 10-row sample first. No account, no payment.